Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
merck
2
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
aduro biotech
agency
akili interactive labs
alicia hager
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
What
time
2
×
alliance
approved
bio
bristol
buy
calls
cancer
changing
color
crispr
days
deeper
dna
drug
fda
fingerprint
genetic
going
growing
hours
kudos
leaves
matter
medicine
myers’s
nd
new
notifying
october
oks
phone
rnai
roundup
rouse
scientists
second
shorter
slumber
targets
Language
unset
Current search:
roche
×
merck
×
time
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
